Analyser instrument for HPV diagnostics

Universitetssykehuset Nord-Norge HF

The University Hospital of North Norway henceforth referred to as the Awarding Authority, requests tenders for test reagents, henceforth referred to as analyser platform, for HPB diagnostics which shall be used for secondary screening in connection with mass examinations of cervix cancer. Approx. 1 000-2 000 tests per annum are expected to be taken.
The instrument shall also be used in connection with research and development works for HPV related problems. Among other things, a major research project with HPV testing as a part of primary screening is planned to be implemented in Health Region North.
Such a project will result in considerable requirements for analyses, and the analyser platform’s suitability and price in relation to such project will be considered in connection with assessment of tenders.
The Awarding Authority will also allow for options for expansion with a view to use of the platform in connection with HPV primary screening.
The Awarding Authority therefore requests documentation showing options and costs in relation to expansion of capacity to 20 000-30 000 tests per annum, as well as prices for reagents and consumables associated with analyses of 20 000 tests per annum.
The Awarding Authority also requires investments in relation to instrumentation for molecular pathological analyses. Due to investments and operations, it will be an advantage that the platform is “open”. I.e can be used for molecular genetic diagnostics of oncological markers beyond HPV testing.
This is not a mandatory requirement, but it will be highly regarded in connection with assessment of tenders (user friendliness and functionality).
The Awarding Authority uses Mercell Sourcing Service in this tender procedure. In order to register for participation in the tender contest and get access to the tender documents please click on the link below or copy and paste the link in the net browser and follow the instruction given on the link: http://permalink.mercell.com/31858509.aspx.

Frist

Fristen for mottak av tilbud var 2012-03-16. Anskaffelsen ble publisert 2012-02-08.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2012-02-08 Kunngjøring av konkurranse
2012-09-10 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2012-02-08)
Gjenstand
Anskaffelsens omfang
Tittel: analysis apparatus
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS)
Felles innkjøpsordliste (CPV)
Kode: Analyseapparatur 📦

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Det mest økonomisk fordelaktige tilbudet

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Regional eller lokal myndighet
Navn på tildelende myndighet: Universitetssykehuset Nord-Norge HF
Postadresse: Sykehusveien 38
Postnummer: 9019
Poststed: Tromsø
Kontakt
E-post: britt.mikkelsen@unn.no 📧
Telefon: +47 77628321 📞

Referanse
Datoer
Sendt dato: 2012-02-08 📅
Innleveringsfrist: 2012-03-16 📅
Publiseringsdato: 2012-02-10 📅
Identifikatorer
Kunngjøringsnummer: 2012/S 28-045711
OJ-S-utgave: 28
Tilleggsinformasjon
(NT Ref:249539).

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The University Hospital of North Norway henceforth referred to as the Awarding Authority, requests tenders for test reagents, henceforth referred to as analyser platform, for HPB diagnostics which shall be used for secondary screening in connection with mass examinations of cervix cancer. Approx. 1 000-2 000 tests per annum are expected to be taken.
Vis mer
The instrument shall also be used in connection with research and development works for HPV related problems. Among other things, a major research project with HPV testing as a part of primary screening is planned to be implemented in Health Region North.
Vis mer
Such a project will result in considerable requirements for analyses, and the analyser platform’s suitability and price in relation to such project will be considered in connection with assessment of tenders.
The Awarding Authority will also allow for options for expansion with a view to use of the platform in connection with HPV primary screening.
The Awarding Authority therefore requests documentation showing options and costs in relation to expansion of capacity to 20 000-30 000 tests per annum, as well as prices for reagents and consumables associated with analyses of 20 000 tests per annum.
Vis mer
The Awarding Authority also requires investments in relation to instrumentation for molecular pathological analyses. Due to investments and operations, it will be an advantage that the platform is “open”. I.e can be used for molecular genetic diagnostics of oncological markers beyond HPV testing.
Vis mer
This is not a mandatory requirement, but it will be highly regarded in connection with assessment of tenders (user friendliness and functionality).
The Awarding Authority uses Mercell Sourcing Service in this tender procedure. In order to register for participation in the tender contest and get access to the tender documents please click on the link below or copy and paste the link in the net browser and follow the instruction given on the link: http://permalink.mercell.com/31858509.aspx.
Vis mer
Referansenummer: 9-12
Utførelsessted
Hovedsted eller utførelsessted: Tromsø, Norway.

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
(1) Company registration certificate.
(2) Value added tax certificate (National requirement).
(3) Company tax certificate (National requirement).
(4) Self-declaration in compliance with Appendix 2 (HSE) of the Norwegian procurement regulations (National requirement).
Økonomisk og finansiell stilling:
(1) The company’s most recent annual report including new information of relevance to the company’s accounting figures.
(2) Presentation of the company’s annual accounts, or extracts thereof.
Teknisk og faglig kapasitet:
(1) A list of the principal deliveries effected, or main services provided, by the company, in the past 3 years, with the values, dates and recipients (for supply and service contracts).

Prosedyre
Tilbudets gyldighetsperiode: 2012-08-31 📅
Språk
Andre språk: Norwegian.

Oppdragsgiver
Kontakt
Kontaktpunkt: Britt Mikkelsen

Referanse
Identifikatorer
Referansenummer tildelt av oppdragsgiver: 9-12
Kilde: OJS 2012/S 028-045711 (2012-02-08)
Kunngjøring om tildeling av kontrakt (2012-09-10)
Gjenstand
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Oppdragsgiver
Identitet
Type tildelende myndighet: Offentligrettslig organ

Referanse
Datoer
Sendt dato: 2012-09-10 📅
Publiseringsdato: 2012-09-12 📅
Identifikatorer
Kunngjøringsnummer: 2012/S 175-288419
Refererer til kunngjøring: 2012/S 28-045711
OJ-S-utgave: 175
Tilleggsinformasjon
(NT Ref:267427).

Prosedyre
Tildelingskriterier
Kriterium: 1. Lifetime cost (40)
2. Quality (20)
3. User friendliness and functionality (30)
4. Service (10)

Tildeling av kontrakt
Dato for kontraktinngåelse: 2012-05-02 📅
Navn: Roche Diagnostics Norge AS
Postadresse: PB 6610 Etterstad
Poststed: Oslo
Postnummer: 0607
Land: Norge 🇳🇴
Informasjon om tilbud
Antall mottatte tilbud: 2
Kilde: OJS 2012/S 175-288419 (2012-09-10)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Laboratorie-, optisk- og presisjonsutstyr... Instrumenter til kontroll av fysiske egenskaper Apparater til fysisk eller kjemisk analyse Analyseapparatur